HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights...
New Data Presented at Heart Rhythm Society Conference Demonstrates Continued Progress with Company’s AI Program Data Show That Applying AI to VCG...
Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies HeartBeam...
Continued Clinical and Regulatory Progress on the AIMIGo™ 3D VECG System Presented Positive Results on its Artificial Intelligence Capabilities...
New Data Presented at the European Heart Rhythm Association Conference Marks First Scientific Presentation on HeartBeam AI, the Company’s Deep...
First Patients Enrolled in Pivotal Study Evaluating AIMIGo™ System for Synthesizing a 12-Lead ECG Ongoing Clinical and Regulatory Progress for...
VALID-ECG Study will Form the Basis of the Company’s Upcoming FDA 510(k) Submission HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company...
Company Continues Expanding its Intellectual Property Footprint, Now has 14 US and 4 International Patents HeartBeam, Inc. (NASDAQ: BEAT), a...
Company Appoints Mohammad Shokoohi-Yekta to Lead Program and Industry Pioneer Lance Myers as Advisor HeartBeam, Inc. (NASDAQ: BEAT), a medical...
Strengthens Leadership with Appointments to Executive Team and Boards Publishes Landmark Peer-Reviewed Article, Validating Technology Ongoing...
Company Adds Leading Cardiologists to Provide Strategic Insights HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed...
New Patent Extends Intellectual Property Footprint for Company’s Groundbreaking Technology in Large ECG Patch Monitor Market HeartBeam, Inc...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.